BRIEF-Eli Lilly Spokesperson Says No One Should Be Mass-Compounding Or Selling Knockoff Glp-1 Products Regardless Of How They’re Administered
Hims & Hers Health +8.85% Pre
Eli Lilly and Company -1.06% Pre
Hims & Hers Health HIMS | 21.15 21.58 | +8.85% +2.03% Pre |
Eli Lilly and Company LLY | 929.55 929.55 | -1.06% 0.00% Pre |
Feb 7 (Reuters) - Eli Lilly and Co LLY.N:
ELI LILLY SOKESPERSON: LOOK FORWARD TO DECISIVE STEPS FDA HAS ANNOUNCED IT WILL TAKE, AND WE URGE OTHER REGULATORS AND LAW ENFORCEMENT TO DO THE SAME
ELI LILLY SPOKESPERSON: NO ONE SHOULD BE MASS-COMPOUNDING OR SELLING KNOCKOFF GLP-1 PRODUCTS REGARDLESS OF HOW THEY’RE ADMINISTERED
Source text: [ID:]
Further company coverage: LLY.N
